Harding Loevner’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $8K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $6K | Hold |
|
|||||
|
2021
Q1 | $5K | Sell |
|
|||||
|
2020
Q4 | $13K | Sell |
|
|||||
|
2020
Q3 | $16K | Sell |
|
|||||
|
2020
Q2 | $18K | Sell |
|
|||||
|
2020
Q1 | $8.18M | Sell |
|
|||||
|
2019
Q4 | $228M | Sell |
|
|||||
|
2019
Q3 | $192M | Buy |
|
|||||
|
2019
Q2 | $216M | Sell |
|
|||||
|
2019
Q1 | $287M | Buy |
|
|||||
|
2018
Q4 | $254M | Buy |
|
|||||
|
2018
Q3 | $257M | Buy |
|
|||||
|
2018
Q2 | $213M | Sell |
|
|||||
|
2018
Q1 | $216M | Sell |
|
|||||
|
2017
Q4 | $238M | Sell |
|
|||||
|
2017
Q3 | $290M | Buy |
|
|||||
|
2017
Q2 | $261M | Sell |
|
|||||
|
2017
Q1 | $216M | Buy |
|
|||||
|
2016
Q4 | $116M | Sell |
|
|||||
|
2016
Q3 | $128M | Buy |
|
|||||
|
2016
Q2 | $58M | Buy |
|